{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:13:26Z","timestamp":1794287606694,"version":"4.9.0"},"reference-count":287,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"DOI":"10.1038\/s41569-026-01295-7","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:02:00Z","timestamp":1777993320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CD8+ T cells in atherosclerosis and coronary artery disease"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-8638","authenticated-orcid":false,"given":"Ishita","family":"Tandon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Yosri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeer","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa M.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9339-3672","authenticated-orcid":false,"given":"Klaus","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7865-9898","authenticated-orcid":false,"given":"Hossam A.","family":"Abdelsamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"1295_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5334\/gh.1288","volume":"19","author":"M Di Cesare","year":"2024","unstructured":"Di Cesare, M. et al. The heart of the world. Glob. Heart 19, 11 (2024).","journal-title":"Glob. Heart"},{"key":"1295_CR2","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin, S. S. et al. 2024 heart disease and stroke statistics: a report of US and global data from the american heart association. Circulation 149, e347\u2013e913 (2024).","journal-title":"Circulation"},{"key":"1295_CR3","unstructured":"World Health Organization. Cardiovascular Diseases (CVDs) (WHO, 2025); https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-%28cvds%29."},{"key":"1295_CR4","doi-asserted-by":"publisher","first-page":"8062","DOI":"10.3390\/ijms24098062","volume":"24","author":"M Kumric","year":"2023","unstructured":"Kumric, M. et al. Emerging therapies for the treatment of atherosclerotic cardiovascular disease: from bench to bedside. Int. J. Mol. Sci. 24, 8062 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1295_CR5","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3389\/fcvm.2020.631398","volume":"7","author":"J Ma","year":"2021","unstructured":"Ma, J. & Chen, X. Anti-inflammatory therapy for coronary atherosclerotic heart disease: unanswered questions behind existing successes. Front. Cardiovasc. Med. 7, 2020 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1295_CR6","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/life13081669","volume":"13","author":"Y Dimitroglou","year":"2023","unstructured":"Dimitroglou, Y. et al. Novel anti-inflammatory therapies in coronary artery disease and acute coronary syndromes. Life 13, 1669 (2023).","journal-title":"Life"},{"key":"1295_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf, D. & Ley, K. Immunity and inflammation in atherosclerosis. Circ. Res. 124, 315\u2013327 (2019).","journal-title":"Circ. Res."},{"key":"1295_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/CIRCRESAHA.117.304611","volume":"117","author":"C Cochain","year":"2015","unstructured":"Cochain, C. et al. CD8+ T cells regulate monopoiesis and circulating ly6chigh monocyte levels in atherosclerosis in mice. Circ. Res. 117, 244\u2013253 (2015).","journal-title":"Circ. Res."},{"key":"1295_CR9","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/S0002-9440(10)63252-X","volume":"165","author":"R Elhage","year":"2004","unstructured":"Elhage, R. et al. Deleting TCR\u03b1\u03b2+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am. J. Pathol. 165, 2013\u20132018 (2004).","journal-title":"Am. J. Pathol."},{"key":"1295_CR10","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1172\/JCI117622","volume":"94","author":"AI Fyfe","year":"1994","unstructured":"Fyfe, A. I., Qiao, J. H. & Lusis, A. J. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J. Clin. Invest. 94, 2516\u20132520 (1994).","journal-title":"J. Clin. Invest."},{"key":"1295_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078939","volume":"8","author":"PR Hiebert","year":"2013","unstructured":"Hiebert, P. R., Boivin, W. A., Zhao, H., McManus, B. M. & Granville, D. J. Perforin and granzyme B have separate and distinct roles during atherosclerotic plaque development in apolipoprotein E knockout mice. PLoS ONE 8, e78939 (2013).","journal-title":"PLoS ONE"},{"key":"1295_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033932","volume":"7","author":"D Kolbus","year":"2012","unstructured":"Kolbus, D. et al. TAP1-deficiency does not alter atherosclerosis development in Apoe\u2212\/\u2212 mice. PLoS ONE 7, e33932 (2012).","journal-title":"PLoS ONE"},{"key":"1295_CR13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.112.001347","volume":"127","author":"T Kyaw","year":"2013","unstructured":"Kyaw, T. et al. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoe-deficient mice. Circulation 127, 1028\u20131039 (2013).","journal-title":"Circulation"},{"key":"1295_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53642-z","volume":"9","author":"FH Schaftenaar","year":"2019","unstructured":"Schaftenaar, F. H. et al. Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model. Sci. Rep. 9, 17391 (2019).","journal-title":"Sci. Rep."},{"key":"1295_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/01.ATV.6.2.131","volume":"6","author":"L Jonasson","year":"1986","unstructured":"Jonasson, L., Holm, J., Skalli, O., Bondjers, G. & Hansson, G. K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131\u2013138 (1986).","journal-title":"Arteriosclerosis"},{"key":"1295_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/ATVBAHA.120.312137","volume":"41","author":"H Winkels","year":"2021","unstructured":"Winkels, H. & Wolf, D. Heterogeneity of T cells in atherosclerosis defined by single-cell RNA-sequencing and cytometry by time of flight. Arterioscler. Thromb. Vasc. Biol. 41, 549\u2013563 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/ATVBAHA.121.315849","volume":"42","author":"N Eberhardt","year":"2022","unstructured":"Eberhardt, N. & Giannarelli, C. How single-cell technologies have provided new insights into atherosclerosis. Arterioscler., Thromb., Vasc. Biol. 42, 243\u2013252 (2022).","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"1295_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","volume":"17","author":"R Saigusa","year":"2020","unstructured":"Saigusa, R., Winkels, H. & Ley, K. T cell subsets and functions in atherosclerosis. Nat. Rev. Cardiol. 17, 387\u2013401 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"1295_CR19","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","volume":"25","author":"DM Fernandez","year":"2019","unstructured":"Fernandez, D. M. et al. Single-cell immune landscape of human atherosclerotic plaques. Nat. Med. 25, 1576\u20131588 (2019).","journal-title":"Nat. Med."},{"key":"1295_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113380","volume":"42","author":"JV Mosquera","year":"2023","unstructured":"Mosquera, J. V. et al. Integrative single-cell meta-analysis reveals disease-relevant vascular cell states and markers in human atherosclerosis. Cell Rep. 42, 113380 (2023).","journal-title":"Cell Rep."},{"key":"1295_CR21","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s43587-023-00515-w","volume":"3","author":"DJ Tyrrell","year":"2023","unstructured":"Tyrrell, D. J. et al. Clonally expanded memory CD8+ T cells accumulate in atherosclerotic plaques and are pro-atherogenic in aged mice. Nat. Aging 3, 1576\u20131590 (2023).","journal-title":"Nat. Aging"},{"key":"1295_CR22","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/ATVBAHA.123.320524","volume":"44","author":"AC Bashore","year":"2024","unstructured":"Bashore, A. C. et al. High-dimensional single-cell multimodal landscape of human carotid atherosclerosis. Arterioscler., Thromb., Vasc. Biol. 44, 930\u2013945 (2024).","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"1295_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02810-0","volume":"20","author":"Z Shi","year":"2023","unstructured":"Shi, Z. et al. Granzyme B+ CD8+ T cells with terminal differentiated effector signature determine multiple sclerosis progression. J. Neuroinflammation 20, 138 (2023).","journal-title":"J. Neuroinflammation"},{"key":"1295_CR24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171359","volume":"8","author":"J Slysz","year":"2023","unstructured":"Slysz, J. et al. Single-cell profiling reveals inflammatory polarization of human carotid versus femoral plaque leukocytes. JCI Insight 8, e171359 (2023).","journal-title":"JCI Insight"},{"key":"1295_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s44325-025-00056-8","volume":"2","author":"X Su","year":"2025","unstructured":"Su, X., O\u2019Hare, K. A. & Freeman, M. L. Mechanisms and implications of vascular-homing CD8 T cells in atherosclerosis. npj Cardiovasc. Health 2, 19 (2025).","journal-title":"npj Cardiovasc. Health"},{"key":"1295_CR26","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/CIRCRESAHA.114.301137","volume":"114","author":"SK Mohanta","year":"2014","unstructured":"Mohanta, S. K. et al. Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis. Circ. Res. 114, 1772\u20131787 (2014).","journal-title":"Circ. Res."},{"key":"1295_CR27","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.humpath.2008.04.018","volume":"39","author":"J Gewaltig","year":"2008","unstructured":"Gewaltig, J., Kummer, M., Koella, C., Cathomas, G. & Biedermann, B. C. Requirements for CD8 T-cell migration into the human arterial wall. Hum. Pathol. 39, 1756\u20131762 (2008).","journal-title":"Hum. Pathol."},{"key":"1295_CR28","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1161\/01.ATV.0000187470.31662.fe","volume":"25","author":"MPW Moos","year":"2005","unstructured":"Moos, M. P. W. et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25, 2386\u20132391 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR29","doi-asserted-by":"publisher","first-page":"1239148","DOI":"10.3389\/fimmu.2023.1239148","volume":"14","author":"S Iqneibi","year":"2023","unstructured":"Iqneibi, S. et al. Single cell transcriptomics reveals recent CD8 T cell receptor signaling in patients with coronary artery disease. Front. Immunol. 14, 1239148 (2023).","journal-title":"Front. Immunol."},{"key":"1295_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1161\/ATVBAHA.115.306112","volume":"36","author":"DA Zidar","year":"2016","unstructured":"Zidar, D. A. et al. Altered maturation status and possible immune exhaustion of CD8 T lymphocytes in the peripheral blood of patients presenting with acute coronary syndromes. Arterioscler. Thromb. Vasc. Biol. 36, 389\u2013397 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR31","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.7150\/thno.73336","volume":"12","author":"L Fan","year":"2022","unstructured":"Fan, L. et al. High-dimensional single-cell analysis delineates peripheral immune signature of coronary atherosclerosis in human blood. Theranostics 12, 6809\u20136825 (2022).","journal-title":"Theranostics"},{"key":"1295_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijcard.2018.01.079","volume":"259","author":"J Podolec","year":"2018","unstructured":"Podolec, J. et al. Higher levels of circulating na\u00efve CD8+CD45RA+ cells are associated with lower extent of coronary atherosclerosis and vascular dysfunction. Int. J. Cardiol. 259, 26\u201330 (2018).","journal-title":"Int. J. Cardiol."},{"key":"1295_CR33","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1161\/ATVBAHA.120.315106","volume":"40","author":"LE Padgett","year":"2020","unstructured":"Padgett, L. E. et al. Naive CD8+ T cells expressing CD95 increase human cardiovascular disease severity. Arterioscler. Thromb. Vasc. Biol. 40, 2845\u20132859 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR34","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1161\/ATVBAHA.111.237081","volume":"31","author":"J-C Grivel","year":"2011","unstructured":"Grivel, J.-C. et al. Activation of T lymphocytes in atherosclerotic plaques. Arterioscler., Thromb., Vasc. Biol. 31, 2929\u20132937 (2011).","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"1295_CR35","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1161\/CIRCRESAHA.120.316770","volume":"127","author":"MAC Depuydt","year":"2020","unstructured":"Depuydt, M. A. C. et al. Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics. Circ. Res. 127, 1437\u20131455 (2020).","journal-title":"Circ. Res."},{"key":"1295_CR36","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/eji.202049004","volume":"51","author":"A Komissarov","year":"2021","unstructured":"Komissarov, A. et al. Driving T cells to human atherosclerotic plaques: CCL3\/CCR5 and CX3CL1\/CX3CR1 migration axes. Eur. J. Immunol. 51, 1857\u20131859 (2021).","journal-title":"Eur. J. Immunol."},{"key":"1295_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/01.ATV.12.2.206","volume":"12","author":"S Stemme","year":"1992","unstructured":"Stemme, S., Holm, J. & Hansson, G. K. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Thromb. 12, 206\u2013211 (1992).","journal-title":"Arterioscler. Thromb."},{"key":"1295_CR38","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/CIRCULATIONAHA.107.699173","volume":"117","author":"PS Olofsson","year":"2008","unstructured":"Olofsson, P. S. et al. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 117, 1292\u20131301 (2008).","journal-title":"Circulation"},{"key":"1295_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2018.03.007","volume":"272","author":"L S\u00f6derstr\u00f6m","year":"2018","unstructured":"S\u00f6derstr\u00f6m, L., Tarnawski, L. & Olofsson, P. S. CD137: a checkpoint regulator involved in atherosclerosis. Atherosclerosis 272, 66\u201372 (2018).","journal-title":"Atherosclerosis"},{"key":"1295_CR40","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.immuni.2015.05.015","volume":"42","author":"D Hu","year":"2015","unstructured":"Hu, D. et al. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin \u03b2 receptors. Immunity 42, 1100\u20131115 (2015).","journal-title":"Immunity"},{"key":"1295_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s44161-023-00218-w","volume":"2","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis. Nat. Cardiovasc. Res. 2, 290\u2013306 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1295_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41586-022-04673-6","volume":"605","author":"SK Mohanta","year":"2022","unstructured":"Mohanta, S. K. et al. Neuroimmune cardiovascular interfaces control atherosclerosis. Nature 605, 152\u2013159 (2022).","journal-title":"Nature"},{"key":"1295_CR43","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/ATVBAHA.123.320539","volume":"44","author":"MJM de Jong","year":"2024","unstructured":"de Jong, M. J. M. et al. Virus-associated CD8+ T-cells are not activated through antigen-mediated interaction inside atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 44, 1302\u20131314 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-022-01382-4","volume":"20","author":"J Vallejo","year":"2022","unstructured":"Vallejo, J. et al. Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells. BMC Biol. 20, 193 (2022).","journal-title":"BMC Biol."},{"key":"1295_CR45","doi-asserted-by":"publisher","first-page":"7731","DOI":"10.1073\/pnas.1232420100","volume":"100","author":"E Woolf","year":"2003","unstructured":"Woolf, E. et al. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl Acad. Sci. USA 100, 7731\u20137736 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1295_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/CIRCRESAHA.120.316903","volume":"127","author":"A Zernecke","year":"2020","unstructured":"Zernecke, A. et al. Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas. Circ. Res. 127, 402\u2013426 (2020).","journal-title":"Circ. Res."},{"key":"1295_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.antiviral.2018.12.014","volume":"162","author":"E Bernal","year":"2019","unstructured":"Bernal, E. et al. T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors. Antivir. Res. 162, 163\u2013170 (2019).","journal-title":"Antivir. Res."},{"key":"1295_CR48","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.4049\/jimmunol.2100208","volume":"207","author":"H Winkels","year":"2021","unstructured":"Winkels, H. et al. Thymus-derived CD4+CD8+ cells reside in mediastinal adipose tissue and the aortic arch. J. Immunol. 207, 2720\u20132732 (2021).","journal-title":"J. Immunol."},{"key":"1295_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093293","volume":"9","author":"D Quandt","year":"2014","unstructured":"Quandt, D., Rothe, K., Scholz, R., Baerwald, C. W. & Wagner, U. Peripheral CD4CD8 double positive T cells with a distinct helper cytokine profile are increased in rheumatoid arthritis. PLoS ONE 9, e93293 (2014).","journal-title":"PLoS ONE"},{"key":"1295_CR50","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fimmu.2019.00622","volume":"10","author":"P Bohner","year":"2019","unstructured":"Bohner, P. et al. Double positive CD4+CD8+ T cells are enriched in urological cancers and favor T helper-2 polarization. Front. Immunol. 10, 622 (2019).","journal-title":"Front. Immunol."},{"key":"1295_CR51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/v14010090","volume":"14","author":"ED Yu","year":"2022","unstructured":"Yu, E. D. et al. A population of CD4+CD8+ double-positive T cells associated with risk of plasma leakage in dengue viral infection. Viruses 14, 90 (2022).","journal-title":"Viruses"},{"key":"1295_CR52","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/CIRCRESAHA.124.325841","volume":"136","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. MAIT cells promote cholesterol excretion pathways mitigating atherosclerosis. Circ. Res. 136, 968\u2013981 (2025).","journal-title":"Circ. Res."},{"key":"1295_CR53","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3390\/cells12172152","volume":"12","author":"H Hinkley","year":"2023","unstructured":"Hinkley, H., Counts, D. A., VonCanon, E. & Lacy, M. T cells in atherosclerosis: key players in the pathogenesis of vascular disease. Cells 12, 2152 (2023).","journal-title":"Cells"},{"key":"1295_CR54","first-page":"2024","volume":"15","author":"L Xu","year":"2024","unstructured":"Xu, L., Chen, F., Fan, W., Saito, S. & Cao, D. The role of \u03b3\u03b4T lymphocytes in atherosclerosis. Front. Immunol. 15, 2024 (2024).","journal-title":"Front. Immunol."},{"key":"1295_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10753-016-0456-6","volume":"40","author":"L Cai","year":"2017","unstructured":"Cai, L. et al. Reconfiguration of NKT cell subset compartment is associated with plaque development in patients with carotid artery stenosis. Inflammation 40, 92\u201399 (2017).","journal-title":"Inflammation"},{"key":"1295_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128523","volume":"10","author":"M-K Qiu","year":"2015","unstructured":"Qiu, M.-K. et al. PD-1 and tim-3 pathways regulate CD8+ T cells function in atherosclerosis. PLoS ONE 10, e0128523 (2015).","journal-title":"PLoS ONE"},{"key":"1295_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2019.04.217","volume":"285","author":"J van Duijn","year":"2019","unstructured":"van Duijn, J. et al. CD39 identifies a microenvironment-specific anti-inflammatory CD8+ T-cell population in atherosclerotic lesions. Atherosclerosis 285, 71\u201378 (2019).","journal-title":"Atherosclerosis"},{"key":"1295_CR58","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.3390\/ijms22158068","volume":"22","author":"E Timperi","year":"2021","unstructured":"Timperi, E. & Barnaba, V. CD39 regulation and functions in T cells. Int. J. Mol. Sci. 22, 8068 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1295_CR59","doi-asserted-by":"publisher","first-page":"1327051","DOI":"10.3389\/fimmu.2024.1327051","volume":"15","author":"A Singh","year":"2024","unstructured":"Singh, A. et al. CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization. Front. Immunol. 15, 1327051 (2024).","journal-title":"Front. Immunol."},{"key":"1295_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/eji.200636251","volume":"37","author":"T Kondo","year":"2007","unstructured":"Kondo, T., Takata, H. & Takiguchi, M. Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells. Eur. J. Immunol. 37, 54\u201365 (2007).","journal-title":"Eur. J. Immunol."},{"key":"1295_CR61","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/CIRCULATIONAHA.124.072560","volume":"151","author":"L Parma","year":"2025","unstructured":"Parma, L. et al. CXCL12 derived from ACKR1+ intraplaque neovessels mediates CD8+ T cell recruitment in human atherosclerosis. Circulation 151, 581\u2013584 (2025).","journal-title":"Circulation"},{"key":"1295_CR62","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1161\/CIRCULATIONAHA.118.037953","volume":"139","author":"Y D\u00f6ring","year":"2019","unstructured":"D\u00f6ring, Y. et al. CXCL12 derived from endothelial cells promotes atherosclerosis to drive coronary artery disease. Circulation 139, 1338\u20131340 (2019).","journal-title":"Circulation"},{"key":"1295_CR63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00395-022-00937-4","volume":"117","author":"S Gencer","year":"2022","unstructured":"Gencer, S. et al. Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium. Basic Res. Cardiol. 117, 30 (2022).","journal-title":"Basic Res. Cardiol."},{"key":"1295_CR64","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.3390\/cells11244099","volume":"11","author":"MO Pacheco","year":"2022","unstructured":"Pacheco, M. O., Rocha, F. A., Aloia, T. P. A. & Marti, L. C. Evaluation of atypical chemokine receptor expression in T cell subsets. Cells 11, 4099 (2022).","journal-title":"Cells"},{"key":"1295_CR65","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.88204","volume":"12","author":"H Chen","year":"2023","unstructured":"Chen, H., Qin, Y., Chou, M., Cyster, J. G. & Li, X. Transmembrane protein CD69 acts as an S1PR1 agonist. eLife 12, e88204 (2023).","journal-title":"eLife"},{"key":"1295_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14020123","volume":"14","author":"D Kounatidis","year":"2024","unstructured":"Kounatidis, D. et al. ApoB100 and atherosclerosis: what\u2019s new in the 21st century? Metabolites 14, e88204 (2024).","journal-title":"Metabolites"},{"key":"1295_CR67","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s44161-023-00376-x","volume":"2","author":"I Raposo-Guti\u00e9rrez","year":"2023","unstructured":"Raposo-Guti\u00e9rrez, I., Rodr\u00edguez-Ronchel, A. & Ramiro, A. R. Atherosclerosis antigens as targets for immunotherapy. Nat. Cardiovasc. Res. 2, 1129\u20131147 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1295_CR68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12026-013-8383-1","volume":"56","author":"C Pierides","year":"2013","unstructured":"Pierides, C., Bermudez-Fajardo, A., Fredrikson, G. N., Nilsson, J. & Oviedo-Orta, E. Immune responses elicited by apoB-100-derived peptides in mice. Immunol. Res. 56, 96\u2013108 (2013).","journal-title":"Immunol. Res."},{"key":"1295_CR69","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149741","volume":"7","author":"KY Chyu","year":"2022","unstructured":"Chyu, K. Y. et al. Immunization using ApoB-100 peptide-linked nanoparticles reduces atherosclerosis. JCI Insight 7, e149741 (2022).","journal-title":"JCI Insight"},{"key":"1295_CR70","doi-asserted-by":"crossref","unstructured":"Mandal, K., Jahangiri, M. & Xu, Q. in Handbook of Experimental Pharmacology 723\u2013743 (Springer, 2005).","DOI":"10.1007\/3-540-27661-0_27"},{"key":"1295_CR71","doi-asserted-by":"publisher","first-page":"314","DOI":"10.4330\/wjc.v6.i5.314","volume":"6","author":"N Vuilleumier","year":"2014","unstructured":"Vuilleumier, N., Montecucco, F. & Hartley, O. Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity. World J. Cardiol. 6, 314\u2013326 (2014).","journal-title":"World J. Cardiol."},{"key":"1295_CR72","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nrcardio.2014.91","volume":"11","author":"G Wick","year":"2014","unstructured":"Wick, G., Jakic, B., Buszko, M., Wick, M. C. & Grundtman, C. The role of heat shock proteins in atherosclerosis. Nat. Rev. Cardiol. 11, 516\u2013529 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"1295_CR73","doi-asserted-by":"publisher","first-page":"723539","DOI":"10.1155\/2008\/723539","volume":"2008","author":"N Milioti","year":"2008","unstructured":"Milioti, N., Bermudez-Fajardo, A., Penichet, M. L. & Oviedo-Orta, E. Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. Clin. Dev. Immunol. 2008, 723539 (2008).","journal-title":"Clin. Dev. Immunol."},{"key":"1295_CR74","doi-asserted-by":"publisher","first-page":"12752","DOI":"10.1073\/pnas.220427097","volume":"97","author":"B Ludewig","year":"2000","unstructured":"Ludewig, B. et al. Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc. Natl Acad. Sci. USA 97, 12752\u201312757 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1295_CR75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.exger.2007.11.009","volume":"43","author":"A Rossmann","year":"2008","unstructured":"Rossmann, A. et al. T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Exp. Gerontol. 43, 229\u2013237 (2008).","journal-title":"Exp. Gerontol."},{"key":"1295_CR76","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2006.09.021","volume":"195","author":"M Knoflach","year":"2007","unstructured":"Knoflach, M. et al. T-cell reactivity against HSP60 relates to early but not advanced atherosclerosis. Atherosclerosis 195, 333\u2013338 (2007).","journal-title":"Atherosclerosis"},{"key":"1295_CR77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaut.2012.07.006","volume":"39","author":"G Almanzar","year":"2012","unstructured":"Almanzar, G. et al. Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions. J. Autoimmun. 39, 441\u2013450 (2012).","journal-title":"J. Autoimmun."},{"key":"1295_CR78","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005318","volume":"6","author":"PC Dimayuga","year":"2017","unstructured":"Dimayuga, P. C. et al. Identification of apoB-100 peptide-specific CD8+ T cells in atherosclerosis. J. Am. Heart Assoc. 6, e005318 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"1295_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030780","volume":"7","author":"KY Chyu","year":"2012","unstructured":"Chyu, K. Y. et al. CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide. PLoS ONE 7, e30780 (2012).","journal-title":"PLoS ONE"},{"key":"1295_CR80","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jacc.2014.11.054","volume":"65","author":"T Honjo","year":"2015","unstructured":"Honjo, T. et al. ApoB-100-related peptide vaccine protects against angiotensin II-induced aortic aneurysm formation and rupture. J. Am. Coll. Cardiol. 65, 546\u2013556 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1295_CR81","doi-asserted-by":"publisher","first-page":"929078","DOI":"10.3389\/fcvm.2022.929078","volume":"9","author":"Q Wang","year":"2022","unstructured":"Wang, Q., Wang, Y. & Xu, D. Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis. Front. Cardiovasc. Med. 9, 929078 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1295_CR82","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s44161-022-00208-4","volume":"2","author":"MAC Depuydt","year":"2023","unstructured":"Depuydt, M. A. C. et al. Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells. Nat. Cardiovasc. Res. 2, 112\u2013125 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1295_CR83","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/CIRCRESAHA.121.320090","volume":"130","author":"RR Chowdhury","year":"2022","unstructured":"Chowdhury, R. R. et al. Human coronary plaque T cells are clonal and cross-react to virus and self. Circ. Res. 130, 1510\u20131530 (2022).","journal-title":"Circ. Res."},{"key":"1295_CR84","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/01.ATV.20.1.10","volume":"20","author":"G Paulsson","year":"2000","unstructured":"Paulsson, G., Zhou, X., T\u00f6rnquist, E. & Hansson, G. K. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20, 10\u201317 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR85","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1161\/hs0901.095633","volume":"32","author":"ZG Nadareishvili","year":"2001","unstructured":"Nadareishvili, Z. G. et al. Increased CD8+ T cells associated with chlamydia pneumoniae in symptomatic carotid plaque. Stroke 32, 1966\u20131972 (2001).","journal-title":"Stroke"},{"key":"1295_CR86","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.jacc.2023.04.008","volume":"81","author":"J Sun","year":"2023","unstructured":"Sun, J. et al. Spatial transcriptional mapping reveals site-specific pathways underlying human atherosclerotic plaque rupture. J. Am. Coll. Cardiol. 81, 2213\u20132227 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1295_CR87","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.3390\/jcm11133832","volume":"11","author":"CV Cristescu","year":"2022","unstructured":"Cristescu, C. V., Alain, S. & Ru\u021b\u0103, S. M. The role of CMV infection in primary lesions, development and clinical expression of atherosclerosis. J. Clin. Med. 11, 3832 (2022).","journal-title":"J. Clin. Med."},{"key":"1295_CR88","doi-asserted-by":"publisher","first-page":"1465889","DOI":"10.3389\/fimmu.2024.1465889","volume":"15","author":"M Yosri","year":"2024","unstructured":"Yosri, M., Dokhan, M., Aboagye, E., Al Moussawy, M. & Abdelsamed, H. A. Mechanisms governing bystander activation of T cells. Front. Immunol. 15, 1465889 (2024).","journal-title":"Front. Immunol."},{"key":"1295_CR89","first-page":"1","volume":"51","author":"T-S Kim","year":"2019","unstructured":"Kim, T.-S. & Shin, E.-C. The activation of bystander CD8+ T cells and their roles in viral infection. Exp. Mol. Med. 51, 1\u20139 (2019).","journal-title":"Exp. Mol. Med."},{"key":"1295_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44667-0","volume":"15","author":"E Balint","year":"2024","unstructured":"Balint, E. et al. Bystander activated CD8+ T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity. Nat. Commun. 15, 896 (2024).","journal-title":"Nat. Commun."},{"key":"1295_CR91","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/CIRCULATIONAHA.111.034850","volume":"124","author":"M Xia","year":"2011","unstructured":"Xia, M. et al. Immune activation resulting from NKG2D\/ligand interaction promotes atherosclerosis. Circulation 124, 2933\u20132943 (2011).","journal-title":"Circulation"},{"key":"1295_CR92","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029529","volume":"12","author":"C David","year":"2023","unstructured":"David, C. et al. Impact of NKG2D signaling on natural killer and T-cell function in cerebral ischemia. J. Am. Heart Assoc. 12, e029529 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"1295_CR93","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.clim.2013.09.003","volume":"149","author":"N Guerra","year":"2013","unstructured":"Guerra, N. et al. A selective role of NKG2D in inflammatory and autoimmune diseases. Clin. Immunol. 149, 432\u2013439 (2013).","journal-title":"Clin. Immunol."},{"key":"1295_CR94","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.coi.2005.09.014","volume":"17","author":"U Walter","year":"2005","unstructured":"Walter, U. & Santamaria, P. CD8+ T cells in autoimmunity. Curr. Opin. Immunol. 17, 624\u2013631 (2005).","journal-title":"Curr. Opin. Immunol."},{"key":"1295_CR95","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/CIRCULATIONAHA.117.031420","volume":"138","author":"T Kimura","year":"2018","unstructured":"Kimura, T. et al. Regulatory CD4+ T cells recognize major histocompatibility complex class II molecule-restricted peptide epitopes of apolipoprotein B. Circulation 138, 1130\u20131143 (2018).","journal-title":"Circulation"},{"key":"1295_CR96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/cells10010037","volume":"10","author":"S Sch\u00e4fer","year":"2020","unstructured":"Sch\u00e4fer, S. & Zernecke, A. CD8+ T cells in atherosclerosis. Cells 10, 37 (2020).","journal-title":"Cells"},{"key":"1295_CR97","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/CIRCRESAHA.115.306427","volume":"118","author":"DFJ Ketelhuth","year":"2016","unstructured":"Ketelhuth, D. F. J. & Hansson, G. K. Adaptive response of T and B cells in atherosclerosis. Circ. Res. 118, 668\u2013678 (2016).","journal-title":"Circ. Res."},{"key":"1295_CR98","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1042\/BST20200602","volume":"48","author":"K Ley","year":"2020","unstructured":"Ley, K. Role of the adaptive immune system in atherosclerosis. Biochem. Soc. Trans. 48, 2273\u20132281 (2020).","journal-title":"Biochem. Soc. Trans."},{"key":"1295_CR99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00395-016-0589-7","volume":"111","author":"C Cochain","year":"2016","unstructured":"Cochain, C. & Zernecke, A. Protective and pathogenic roles of CD8+ T cells in atherosclerosis. Basic Res. Cardiol. 111, 71 (2016).","journal-title":"Basic Res. Cardiol."},{"key":"1295_CR100","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/cvr\/cvaa286","volume":"117","author":"J van Duijn","year":"2021","unstructured":"van Duijn, J. et al. Tc17 CD8+ T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development. Cardiovasc. Res. 117, 2755\u20132766 (2021).","journal-title":"Cardiovasc. Res."},{"key":"1295_CR101","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1172\/JCI119465","volume":"99","author":"S Gupta","year":"1997","unstructured":"Gupta, S. et al. IFN-\u03b3 potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752\u20132761 (1997).","journal-title":"J. Clin. Invest."},{"key":"1295_CR102","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/joim.12038","volume":"274","author":"D Kolbus","year":"2013","unstructured":"Kolbus, D. et al. Association between CD8+ T-cell subsets and cardiovascular disease. J. Intern. Med. 274, 41\u201351 (2013).","journal-title":"J. Intern. Med."},{"key":"1295_CR103","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1084\/jem.20091429","volume":"207","author":"CC Oliveira","year":"2010","unstructured":"Oliveira, C. C. et al. The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. J. Exp. Med. 207, 207\u2013221 (2010).","journal-title":"J. Exp. Med."},{"key":"1295_CR104","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nm1381","volume":"12","author":"T van Hall","year":"2006","unstructured":"van Hall, T. et al. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat. Med. 12, 417\u2013424 (2006).","journal-title":"Nat. Med."},{"key":"1295_CR105","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0092-8674(05)80068-6","volume":"71","author":"L Van Kaer","year":"1992","unstructured":"Van Kaer, L., Ashton-Rickardt, P. G., Ploegh, H. L. & Tonegawa, S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4\u20138+ T cells. Cell 71, 1205\u20131214 (1992).","journal-title":"Cell"},{"key":"1295_CR106","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/eurheartj\/ehy714","volume":"40","author":"TTP Seijkens","year":"2019","unstructured":"Seijkens, T. T. P. et al. Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death. Eur. Heart J. 40, 372\u2013382 (2019).","journal-title":"Eur. Heart J."},{"key":"1295_CR107","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1046\/j.1365-2567.1996.473536.x","volume":"87","author":"E Hornquist","year":"1996","unstructured":"Hornquist, E., Grdic, D., Mak, T. & Lycke, N. CD8-deficient mice exhibit augmented mucosal immune responses and intact adjuvant effects to cholera toxin. Immunology 87, 220\u2013229 (1996).","journal-title":"Immunology"},{"key":"1295_CR108","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.cca.2012.04.031","volume":"413","author":"M Wigren","year":"2012","unstructured":"Wigren, M., Nilsson, J. & Kolbus, D. Lymphocytes in atherosclerosis. Clin. Chim. Acta 413, 1562\u20131568 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"1295_CR109","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.bbrc.2013.12.057","volume":"443","author":"J Zhou","year":"2014","unstructured":"Zhou, J. et al. CD8+CD25+ T cells reduce atherosclerosis in apoE\u2212\/\u2212 mice. Biochem. Biophys. Res. Commun. 443, 864\u2013870 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1295_CR110","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/CIRCULATIONAHA.114.010988","volume":"131","author":"M Clement","year":"2015","unstructured":"Clement, M. et al. Control of the T follicular helper\u2013germinal center B-cell axis by CD8+ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation 131, 560\u2013570 (2015).","journal-title":"Circulation"},{"key":"1295_CR111","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi9591","volume":"376","author":"J Li","year":"2022","unstructured":"Li, J. et al. KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science 376, eabi9591 (2022).","journal-title":"Science"},{"key":"1295_CR112","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/01.RES.0000082333.58263.58","volume":"93","author":"T Nakajima","year":"2003","unstructured":"Nakajima, T. et al. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ. Res. 93, 106\u2013113 (2003).","journal-title":"Circ. Res."},{"key":"1295_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01990-3","volume":"22","author":"Z-X Wu","year":"2024","unstructured":"Wu, Z.-X. et al. CD69+CD103+CD8+ tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer. Cell Commun. Signal. 22, 608 (2024).","journal-title":"Cell Commun. Signal."},{"key":"1295_CR114","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/ATVBAHA.123.320511","volume":"44","author":"MJM de Jong","year":"2024","unstructured":"de Jong, M. J. M. et al. Resident memory T cells in the atherosclerotic lesion associate with reduced macrophage content and increased lesion stability. Arterioscler. Thromb. Vasc. Biol. 44, 1318\u20131329 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR115","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/cvr\/cvy261","volume":"115","author":"J van Duijn","year":"2018","unstructured":"van Duijn, J. et al. CD8+ T-cells contribute to lesion stabilization in advanced atherosclerosis by limiting macrophage content and CD4+ T-cell responses. Cardiovasc. Res. 115, 729\u2013738 (2018).","journal-title":"Cardiovasc. Res."},{"key":"1295_CR116","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2172-11-58","volume":"11","author":"D Kolbus","year":"2010","unstructured":"Kolbus, D. et al. CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe\u2212\/\u2212 mice. BMC Immunol. 11, 58 (2010).","journal-title":"BMC Immunol."},{"key":"1295_CR117","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.111.061986","volume":"125","author":"CS Robbins","year":"2012","unstructured":"Robbins, C. S. et al. Extramedullary hematopoiesis generates Ly-6Chigh monocytes that infiltrate atherosclerotic lesions. Circulation 125, 364\u2013374 (2012).","journal-title":"Circulation"},{"key":"1295_CR118","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1172\/JCI29950","volume":"117","author":"FK Swirski","year":"2007","unstructured":"Swirski, F. K. et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195\u2013205 (2007).","journal-title":"J. Clin. Invest."},{"key":"1295_CR119","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.stem.2014.01.002","volume":"14","author":"CM Sch\u00fcrch","year":"2014","unstructured":"Sch\u00fcrch, C. M., Riether, C. & Ochsenbein, A. F. Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell 14, 460\u2013472 (2014).","journal-title":"Cell Stem Cell"},{"key":"1295_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008885","volume":"16","author":"S Panigrahi","year":"2020","unstructured":"Panigrahi, S. et al. CX3CL1 and IL-15 promote CD8 T cell chemoattraction in HIV and in atherosclerosis. PLoS Pathog. 16, e1008885 (2020).","journal-title":"PLoS Pathog."},{"key":"1295_CR121","doi-asserted-by":"publisher","first-page":"1084841","DOI":"10.3389\/fcimb.2022.1084841","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. IL-15 induced bystander activation of CD8+ T cells may mediate endothelium injury through NKG2D in Hantaan virus infection. Front. Cell. Infect. Microbiol. 12, 1084841 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1295_CR122","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e11","volume":"24","author":"H Lee","year":"2024","unstructured":"Lee, H., Park, S.-H. & Shin, E.-C. IL-15 in T-cell responses and immunopathogenesis. Immune Netw. 24, e11 (2024).","journal-title":"Immune Netw."},{"key":"1295_CR123","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1172\/JCI135060","volume":"130","author":"CB Xie","year":"2020","unstructured":"Xie, C. B. et al. Complement-activated interferon-\u03b3-primed human endothelium transpresents interleukin-15 to CD8+ T cells. J. Clin. Invest. 130, 3437\u20133452 (2020).","journal-title":"J. Clin. Invest."},{"key":"1295_CR124","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","volume":"122","author":"A Grebe","year":"2018","unstructured":"Grebe, A., Hoss, F. & Latz, E. NLRP3 inflammasome and the IL-1 pathway in atherosclerosis. Circ. Res. 122, 1722\u20131740 (2018).","journal-title":"Circ. Res."},{"key":"1295_CR125","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1084\/jem.190.1.9","volume":"190","author":"P Estess","year":"1999","unstructured":"Estess, P., Nandi, A., Mohamadzadeh, M. & Siegelman, M. H. Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo. J. Exp. Med. 190, 9\u201319 (1999).","journal-title":"J. Exp. Med."},{"key":"1295_CR126","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.vaccine.2010.11.037","volume":"29","author":"T van Es","year":"2011","unstructured":"van Es, T. et al. IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice. Vaccine 29, 976\u2013983 (2011).","journal-title":"Vaccine"},{"key":"1295_CR127","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0002-9440(10)61712-9","volume":"159","author":"DM Wuttge","year":"2001","unstructured":"Wuttge, D. M., Eriksson, P., Sirsj\u00f6, A., Hansson, G. K. & Stemme, S. Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am. J. Pathol. 159, 417\u2013423 (2001).","journal-title":"Am. J. Pathol."},{"key":"1295_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.827786","volume":"13","author":"J Wienke","year":"2022","unstructured":"Wienke, J. et al. T cell interaction with activated endothelial cells primes for tissue-residency. Front. Immunol. 13, 827786 (2022).","journal-title":"Front. Immunol."},{"key":"1295_CR129","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/biomedicines13010026","volume":"13","author":"H Shen","year":"2025","unstructured":"Shen, H. et al. The pathogenic role of expanded CD8+CD28null angiogenic T cells in ANCA-associated vasculitis. Biomedicines 13, 26 (2025).","journal-title":"Biomedicines"},{"key":"1295_CR130","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/cvr\/cvab046","volume":"117","author":"MOJ Grootaert","year":"2021","unstructured":"Grootaert, M. O. J. & Bennett, M. R. Vascular smooth muscle cells in atherosclerosis: time for a re-assessment. Cardiovasc. Res. 117, 2326\u20132339 (2021).","journal-title":"Cardiovasc. Res."},{"key":"1295_CR131","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.jacc.2012.03.012","volume":"59","author":"Y Kataoka","year":"2012","unstructured":"Kataoka, Y. et al. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J. Am. Coll. Cardiol. 59, 1592\u20131597 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1295_CR132","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/ATVBAHA.123.320084","volume":"44","author":"S Sch\u00e4fer","year":"2024","unstructured":"Sch\u00e4fer, S. et al. CD8+ T cells drive plaque smooth muscle cell dedifferentiation in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 44, 1852\u20131872 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR133","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.ajpath.2017.02.012","volume":"187","author":"E Nagy","year":"2017","unstructured":"Nagy, E. et al. Interferon-\u03b3 released by activated CD8+ T lymphocytes impairs the calcium resorption potential of osteoclasts in calcified human aortic valves. Am. J. Pathol. 187, 1413\u20131425 (2017).","journal-title":"Am. J. Pathol."},{"key":"1295_CR134","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/CIRCULATIONAHA.109.882704","volume":"121","author":"HJ Jeon","year":"2010","unstructured":"Jeon, H. J. et al. CD137 (4\u20131BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation 121, 1124\u20131133 (2010).","journal-title":"Circulation"},{"key":"1295_CR135","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2016.03.038","volume":"249","author":"Y Hwang","year":"2016","unstructured":"Hwang, Y. et al. Expansion of CD8+ T cells lacking the IL-6 receptor \u03b1 chain in patients with coronary artery diseases (CAD). Atherosclerosis 249, 44\u201351 (2016).","journal-title":"Atherosclerosis"},{"key":"1295_CR136","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00011-023-01703-5","volume":"72","author":"Q Li","year":"2023","unstructured":"Li, Q. et al. Blocking of programmed cell death-ligand 1 (PD-L1) expressed on endothelial cells promoted the recruitment of CD8+IFN-\u03b3+ T cells in atherosclerosis. Inflamm. Res. 72, 783\u2013796 (2023).","journal-title":"Inflamm. Res."},{"key":"1295_CR137","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11883-025-01279-x","volume":"27","author":"D Ramoni","year":"2025","unstructured":"Ramoni, D. et al. Inflammation-driven plaque erosion in atherosclerosis: a focus on complement system pathways. Curr. Atheroscler. Rep. 27, 42 (2025).","journal-title":"Curr. Atheroscler. Rep."},{"key":"1295_CR138","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon, J. F., Otsuka, F., Virmani, R. & Falk, E. Mechanisms of plaque formation and rupture. Circ. Res. 114, 1852\u20131866 (2014).","journal-title":"Circ. Res."},{"key":"1295_CR139","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/eurheartj\/ehad720","volume":"45","author":"C Baaten","year":"2024","unstructured":"Baaten, C., Nagy, M., Bergmeier, W., Spronk, H. M. H. & van der Meijden, P. E. J. Platelet biology and function: plaque erosion vs. rupture. Eur. Heart J. 45, 18\u201331 (2024).","journal-title":"Eur. Heart J."},{"key":"1295_CR140","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1093\/eurheartj\/ehaa703","volume":"41","author":"DM Leistner","year":"2020","unstructured":"Leistner, D. M. et al. Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study. Eur. Heart J. 41, 3549\u20133560 (2020).","journal-title":"Eur. Heart J."},{"key":"1295_CR141","doi-asserted-by":"publisher","first-page":"956078","DOI":"10.3389\/fimmu.2022.956078","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning. Front. Immunol. 13, 956078 (2022).","journal-title":"Front. Immunol."},{"key":"1295_CR142","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby, P. Inflammation in atherosclerosis. Nature 420, 868\u2013874 (2002).","journal-title":"Nature"},{"key":"1295_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122306","volume":"336","author":"P Barbosa","year":"2024","unstructured":"Barbosa, P. et al. CD8+ Treg cells play a role in the obesity-associated insulin resistance. Life Sci. 336, 122306 (2024).","journal-title":"Life Sci."},{"key":"1295_CR144","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/cells9122665","volume":"9","author":"AJ Ali","year":"2020","unstructured":"Ali, A. J., Makings, J. & Ley, K. Regulatory T cell stability and plasticity in atherosclerosis. Cells 9, 2665 (2020).","journal-title":"Cells"},{"key":"1295_CR145","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/ijms21051835","volume":"21","author":"A Poznyak","year":"2020","unstructured":"Poznyak, A. et al. The diabetes mellitus\u2013atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int. J. Mol. Sci. 21, 1835 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1295_CR146","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41423-024-01224-z","volume":"21","author":"Y Tang","year":"2024","unstructured":"Tang, Y., Chen, Z., Zuo, Q. & Kang, Y. Regulation of CD8+ T cells by lipid metabolism in cancer progression. Cell. Mol. Immunol. 21, 1215\u20131230 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"1295_CR147","doi-asserted-by":"publisher","first-page":"945980","DOI":"10.3389\/fimmu.2022.945980","volume":"13","author":"A Bensussen","year":"2022","unstructured":"Bensussen, A., Santana, M. A. & Rodr\u00edguez-Jorge, O. Metabolic alterations impair differentiation and effector functions of CD8+ T cells. Front. Immunol. 13, 945980 (2022).","journal-title":"Front. Immunol."},{"key":"1295_CR148","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.7150\/thno.40663","volume":"10","author":"C Liang","year":"2020","unstructured":"Liang, C. et al. CD8+ T-cell plasticity regulates vascular regeneration in type-2 diabetes. Theranostics 10, 4217\u20134232 (2020).","journal-title":"Theranostics"},{"key":"1295_CR149","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s44161-024-00582-1","volume":"4","author":"T Bleckwehl","year":"2025","unstructured":"Bleckwehl, T. et al. Encompassing view of spatial and single-cell RNA sequencing renews the role of the microvasculature in human atherosclerosis. Nat. Cardiovasc. Res. 4, 26\u201344 (2025).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1295_CR150","doi-asserted-by":"publisher","first-page":"849538","DOI":"10.3389\/fcvm.2022.849538","volume":"9","author":"Y Diao","year":"2022","unstructured":"Diao, Y., Liu, Z., Chen, L., Zhang, W. & Sun, D. The relationship between cancer and functional and structural markers of subclinical atherosclerosis: a systematic review and meta-analysis. Front. Cardiovasc. Med. 9, 849538 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1295_CR151","doi-asserted-by":"publisher","first-page":"1734123","DOI":"10.3389\/fphar.2025.1734123","volume":"16","author":"X Li","year":"2025","unstructured":"Li, X. & Deng, Y. Tumor-like characteristics of vascular smooth muscle cells in atherosclerosis. Front. pharmacol. 16, 1734123 (2025).","journal-title":"Front. pharmacol."},{"key":"1295_CR152","doi-asserted-by":"publisher","unstructured":"Pan, H. et al. Atherosclerosis is a smooth muscle cell\u2013driven tumor-like disease. Circulation https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067587 (2024).","DOI":"10.1161\/CIRCULATIONAHA.123.067587"},{"key":"1295_CR153","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s44161-025-00713-2","volume":"4","author":"M Mulholland","year":"2025","unstructured":"Mulholland, M. et al. Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis. Nat. Cardiovasc. Res. 4, 1311\u20131328 (2025).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1295_CR154","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41422-024-00945-0","volume":"34","author":"L Fan","year":"2024","unstructured":"Fan, L. et al. Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans. Cell Res. 34, 407\u2013427 (2024).","journal-title":"Cell Res."},{"key":"1295_CR155","doi-asserted-by":"publisher","first-page":"876616","DOI":"10.3389\/fimmu.2022.876616","volume":"13","author":"S Zhao","year":"2022","unstructured":"Zhao, S., Wu, Y., Wei, Y., Xu, X. & Zheng, J. Identification of biomarkers associated with CD8+ T cells in coronary artery disease and their pan-cancer analysis. Front. Immunol. 13, 876616 (2022).","journal-title":"Front. Immunol."},{"key":"1295_CR156","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","volume":"602","author":"SV Gearty","year":"2022","unstructured":"Gearty, S. V. et al. An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature 602, 156\u2013161 (2022).","journal-title":"Nature"},{"key":"1295_CR157","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41590-020-0633-5","volume":"21","author":"HA Abdelsamed","year":"2020","unstructured":"Abdelsamed, H. A. et al. Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes. Nat. Immunol. 21, 578\u2013587 (2020).","journal-title":"Nat. Immunol."},{"key":"1295_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-1-1","volume":"1","author":"D Aronson","year":"2002","unstructured":"Aronson, D. & Rayfield, E. J. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc. Diabetol. 1, 1 (2002).","journal-title":"Cardiovasc. Diabetol."},{"key":"1295_CR159","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1073\/pnas.0709958105","volume":"105","author":"F Johansson","year":"2008","unstructured":"Johansson, F. et al. Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. Proc. Natl Acad. Sci. USA 105, 2082\u20132087 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1295_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308461","volume":"11","author":"X Wu","year":"2024","unstructured":"Wu, X. et al. Islet-resident memory T cells orchestrate the immunopathogenesis of type 1 diabetes through the FABP4\u2013CXCL10 axis. Adv. Sci. 11, 2308461 (2024).","journal-title":"Adv. Sci."},{"key":"1295_CR161","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nature05844","volume":"447","author":"M Furuhashi","year":"2007","unstructured":"Furuhashi, M. et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447, 959\u2013965 (2007).","journal-title":"Nature"},{"key":"1295_CR162","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1084\/jem.20021378","volume":"197","author":"AY Savinov","year":"2003","unstructured":"Savinov, A. Y., Wong, F. S., Stonebraker, A. C. & Chervonsky, A. V. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J. Exp. Med. 197, 643\u2013656 (2003).","journal-title":"J. Exp. Med."},{"key":"1295_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38703-2","volume":"14","author":"S Aydin","year":"2023","unstructured":"Aydin, S. et al. Antigen recognition detains CD8+ T cells at the blood-brain barrier and contributes to its breakdown. Nat. Commun. 14, 3106 (2023).","journal-title":"Nat. Commun."},{"key":"1295_CR164","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2337\/db18-0295","volume":"67","author":"M Buitinga","year":"2018","unstructured":"Buitinga, M. et al. Inflammation-induced citrullinated glucose-regulated protein 78 elicits immune responses in human type 1 diabetes. Diabetes 67, 2337\u20132348 (2018).","journal-title":"Diabetes"},{"key":"1295_CR165","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.2337\/db21-0259","volume":"70","author":"ME Azoury","year":"2021","unstructured":"Azoury, M. E. et al. CD8+ T cells variably recognize native versus citrullinated GRP78 epitopes in type 1 diabetes. Diabetes 70, 2879\u20132891 (2021).","journal-title":"Diabetes"},{"key":"1295_CR166","doi-asserted-by":"publisher","first-page":"107067","DOI":"10.1016\/j.clineuro.2021.107067","volume":"212","author":"X Wang","year":"2022","unstructured":"Wang, X., Huang, J., Hou, H. & Chen, D. The relationship with the stability between GRP78, CHOP and human carotid atherosclerotic plaque. Clin. Neurol. Neurosurg. 212, 107067 (2022).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"1295_CR167","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3390\/jcm8111793","volume":"8","author":"J Girona","year":"2019","unstructured":"Girona, J. et al. The circulating GRP78\/BiP is a marker of metabolic diseases and atherosclerosis: bringing endoplasmic reticulum stress into the clinical scenario. J. Clin. Med. 8, 1793 (2019).","journal-title":"J. Clin. Med."},{"key":"1295_CR168","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1161\/ATVBAHA.108.167999","volume":"28","author":"RE Feaver","year":"2008","unstructured":"Feaver, R. E., Hastings, N. E., Pryor, A. & Blackman, B. R. GRP78 upregulation by atheroprone shear stress Via p38-, \u03b12\u03b21-dependent mechanism in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 1534\u20131541 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR169","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99363","volume":"3","author":"ED Crane","year":"2018","unstructured":"Crane, E. D. et al. Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions. JCI Insight 3, e99363 (2018).","journal-title":"JCI Insight"},{"key":"1295_CR170","doi-asserted-by":"publisher","first-page":"103734","DOI":"10.1016\/j.autrev.2024.103734","volume":"24","author":"J Wang","year":"2025","unstructured":"Wang, J., Miao, J. & Zhu, P. Insights into the complexities of citrullination: from immune regulation to autoimmune disease. Autoimmun. Rev. 24, 103734 (2025).","journal-title":"Autoimmun. Rev."},{"key":"1295_CR171","doi-asserted-by":"publisher","first-page":"678953","DOI":"10.3389\/fimmu.2021.678953","volume":"12","author":"ML Yang","year":"2021","unstructured":"Yang, M. L., Sodr\u00e9, F. M. C., Mamula, M. J. & Overbergh, L. Citrullination and PAD enzyme biology in type 1 diabetes \u2014 regulators of inflammation, autoimmunity, and pathology. Front. Immunol. 12, 678953 (2021).","journal-title":"Front. Immunol."},{"key":"1295_CR172","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1161\/CIRCRESAHA.114.303312","volume":"114","author":"JS Knight","year":"2014","unstructured":"Knight, J. S. et al. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ. Res. 114, 947\u2013956 (2014).","journal-title":"Circ. Res."},{"key":"1295_CR173","doi-asserted-by":"publisher","first-page":"147354","DOI":"10.1155\/2012\/147354","volume":"2012","author":"L Cavagna","year":"2012","unstructured":"Cavagna, L. et al. Atherosclerosis and rheumatoid arthritis: more than a simple association. Mediat. Inflamm. 2012, 147354 (2012).","journal-title":"Mediat. Inflamm."},{"key":"1295_CR174","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/art.39419","volume":"68","author":"R Winchester","year":"2016","unstructured":"Winchester, R. et al. Association of elevations of specific T cell and monocyte subpopulations in rheumatoid arthritis with subclinical coronary artery atherosclerosis. Arthritis Rheumatol. 68, 92\u2013102 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1295_CR175","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/annrheumdis-2017-eular.4364","volume":"76","author":"B Wahlin","year":"2017","unstructured":"Wahlin, B. et al. THU0129 Cd8+cd28\u2212 T-lymphocytes are associated with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann. Rheum. Dis. 76, 250 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1295_CR176","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.atherosclerosis.2012.07.033","volume":"224","author":"I Bergstr\u00f6m","year":"2012","unstructured":"Bergstr\u00f6m, I., Backteman, K., Lundberg, A., Ernerudh, J. & Jonasson, L. Persistent accumulation of interferon-\u03b3-producing CD8+CD56+ T cells in blood from patients with coronary artery disease. Atherosclerosis 224, 515\u2013520 (2012).","journal-title":"Atherosclerosis"},{"key":"1295_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35264-8","volume":"14","author":"J-S Moon","year":"2023","unstructured":"Moon, J.-S. et al. Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis. Nat. Commun. 14, 319 (2023).","journal-title":"Nat. Commun."},{"key":"1295_CR178","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/art.37961","volume":"65","author":"J Sokolove","year":"2013","unstructured":"Sokolove, J. et al. Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis. Arthritis Rheum. 65, 1719\u20131724 (2013).","journal-title":"Arthritis Rheum."},{"key":"1295_CR179","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clim.2018.06.006","volume":"194","author":"P Maga","year":"2018","unstructured":"Maga, P. et al. Involvement of CD8+ T cell subsets in early response to vascular injury in patients with peripheral artery disease in vivo. Clin. Immunol. 194, 26\u201333 (2018).","journal-title":"Clin. Immunol."},{"key":"1295_CR180","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/BJ20130481","volume":"454","author":"J Wiejak","year":"2013","unstructured":"Wiejak, J., Dunlop, J., Mackay, S. P. & Yarwood, S. J. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells. Biochem. J. 454, 283\u2013293 (2013).","journal-title":"Biochem. J."},{"key":"1295_CR181","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1210\/clinem\/dgab078","volume":"106","author":"KM Love","year":"2021","unstructured":"Love, K. M. & Liu, Z. DPP4 activity, hyperinsulinemia, and atherosclerosis. J. Clin. Endocrinol. Metab. 106, 1553\u20131565 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR182","doi-asserted-by":"publisher","DOI":"10.1172\/JCI165933","volume":"133","author":"AB Herman","year":"2023","unstructured":"Herman, A. B. et al. DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice. J. Clin. Invest. 133, e165933 (2023).","journal-title":"J. Clin. Invest."},{"key":"1295_CR183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142186","volume":"10","author":"N Alonso","year":"2015","unstructured":"Alonso, N. et al. Type 1 diabetes prevention in NOD mice by targeting DPPIV\/CD26 Is associated with changes in CD8+ T effector memory subset. PLoS ONE 10, e0142186 (2015).","journal-title":"PLoS ONE"},{"key":"1295_CR184","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/imm.12028","volume":"138","author":"R Hatano","year":"2013","unstructured":"Hatano, R., Ohnuma, K., Yamamoto, J., Dang, N. H. & Morimoto, C. CD26-mediated co-stimulation in human CD8+ T cells provokes effector function via pro-inflammatory cytokine production. Immunology 138, 165\u2013172 (2013).","journal-title":"Immunology"},{"key":"1295_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105757","volume":"75","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. CD26 in autoimmune diseases: the other side of \u201cmoonlight protein\u201d. Int. Immunopharmacol. 75, 105757 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"1295_CR186","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1210\/jc.2012-4288","volume":"98","author":"SA Lee","year":"2013","unstructured":"Lee, S. A. et al. CD26\/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 98, 2553\u20132561 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR187","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40164-023-00375-5","volume":"12","author":"N Bozorgmehr","year":"2023","unstructured":"Bozorgmehr, N., Hnatiuk, M., Peters, A. C. & Elahi, S. Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia. Exp. Hematol. Oncol. 12, 13 (2023).","journal-title":"Exp. Hematol. Oncol."},{"key":"1295_CR188","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.3390\/cancers13215495","volume":"13","author":"JM Henderson","year":"2021","unstructured":"Henderson, J. M. et al. Dipeptidyl peptidase inhibition enhances CD8 T cell recruitment and activates intrahepatic inflammasome in a murine model of hepatocellular carcinoma. Cancers 13, 5495 (2021).","journal-title":"Cancers"},{"key":"1295_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121620","volume":"321","author":"R Chakrabarti","year":"2023","unstructured":"Chakrabarti, R. et al. Natural killer T cells and the invariant subset promote atherosclerosis: a meta-analysis. Life Sci. 321, 121620 (2023).","journal-title":"Life Sci."},{"key":"1295_CR190","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/cvr\/cvv259","volume":"109","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE\u2212\/\u2212 mice by reducing lesion necrosis and inflammation. Cardiovasc. Res. 109, 305\u2013317 (2016).","journal-title":"Cardiovasc. Res."},{"key":"1295_CR191","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nri3823","volume":"15","author":"D Klatzmann","year":"2015","unstructured":"Klatzmann, D. & Abbas, A. K. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 15, 283\u2013294 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1295_CR192","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12951-021-01047-4","volume":"19","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. An atherosclerotic plaque-targeted single-chain antibody for MR\/NIR-II imaging of atherosclerosis and anti-atherosclerosis therapy. J. Nanobiotechnol. 19, 296 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"1295_CR193","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","volume":"108","author":"YI Miller","year":"2011","unstructured":"Miller, Y. I. et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108, 235\u2013248 (2011).","journal-title":"Circ. Res."},{"key":"1295_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100391","volume":"64","author":"A Taleb","year":"2023","unstructured":"Taleb, A. et al. High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction. J. Lipid Res. 64, 100391 (2023).","journal-title":"J. Lipid Res."},{"key":"1295_CR195","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jacc.2017.11.036","volume":"71","author":"ML Senders","year":"2018","unstructured":"Senders, M. L. et al. PET\/MR imaging of malondialdehyde\u2013acetaldehyde epitopes with a human antibody detects clinically relevant atherothrombosis. J. Am. Coll. Cardiol. 71, 321\u2013335 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1295_CR196","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.ATV.0000067937.93716.DB","volume":"23","author":"GN Fredrikson","year":"2003","unstructured":"Fredrikson, G. N. et al. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler. Thromb. Vasc. Biol. 23, 879\u2013884 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR197","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1161\/CIRCRESAHA.120.315942","volume":"126","author":"J Nilsson","year":"2020","unstructured":"Nilsson, J. & Hansson, G. K. Vaccination strategies and immune modulation of atherosclerosis. Circ. Res. 126, 1281\u20131296 (2020).","journal-title":"Circ. Res."},{"key":"1295_CR198","doi-asserted-by":"publisher","first-page":"101822","DOI":"10.1016\/j.nantod.2023.101822","volume":"50","author":"MA Moreno-Gonzalez","year":"2023","unstructured":"Moreno-Gonzalez, M. A., Ortega-Rivera, O. A. & Steinmetz, N. F. Two decades of vaccine development against atherosclerosis. Nano Today 50, 101822 (2023).","journal-title":"Nano Today"},{"key":"1295_CR199","doi-asserted-by":"publisher","first-page":"2365500","DOI":"10.1080\/21645515.2024.2365500","volume":"20","author":"B Jia","year":"2024","unstructured":"Jia, B. et al. A bibliometric analysis of vaccination against atherosclerosis. Hum. Vaccin. Immunother. 20, 2365500 (2024).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1295_CR200","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12872-025-04634-7","volume":"25","author":"M Shekarchizadeh Esfahani","year":"2025","unstructured":"Shekarchizadeh Esfahani, M. et al. Immunotherapy and vaccine-based approaches for atherosclerosis prevention: a systematic review study. BMC Cardiovasc. Disord. 25, 201 (2025).","journal-title":"BMC Cardiovasc. Disord."},{"key":"1295_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101535","volume":"33","author":"S Malensek","year":"2025","unstructured":"Malensek, S. et al. Engineering chimeric PCSK9 for a vaccine against atherosclerosis. Mol. Ther. Methods Clin. Dev. 33, 101535 (2025).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1295_CR202","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrcardio.2017.106","volume":"14","author":"D Ummarino","year":"2017","unstructured":"Ummarino, D. Dyslipidaemia: anti-PCSK9 vaccines to halt atherosclerosis. Nat. Rev. Cardiol. 14, 442\u2013443 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"1295_CR203","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s13238-021-00821-2","volume":"12","author":"J Yuan","year":"2021","unstructured":"Yuan, J. et al. Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell 12, 240\u2013260 (2021).","journal-title":"Protein Cell"},{"key":"1295_CR204","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11883-024-01189-4","volume":"26","author":"S Surma","year":"2024","unstructured":"Surma, S., Sahebkar, A. & Banach, M. Correction to: Whether and why do we need a vaccine against atherosclerosis? Can we expect it anytime soon? Curr. Atheroscler. Rep. 26, 73\u201373 (2024).","journal-title":"Curr. Atheroscler. Rep."},{"key":"1295_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106916","volume":"26","author":"Q-C Yang","year":"2023","unstructured":"Yang, Q.-C. et al. Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer. iScience 26, 106916 (2023).","journal-title":"iScience"},{"key":"1295_CR206","doi-asserted-by":"publisher","first-page":"ftv052","DOI":"10.1093\/femspd\/ftv052","volume":"73","author":"MT Zafiratos","year":"2015","unstructured":"Zafiratos, M. T., Manam, S., Henderson, K. K., Ramsey, K. H. & Murthy, A. K. CD8+ T cells mediate chlamydia pneumoniae-induced atherosclerosis in mice. Pathog. Dis. 73, ftv052 (2015).","journal-title":"Pathog. Dis."},{"key":"1295_CR207","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1021\/acs.bioconjchem.4c00590","volume":"36","author":"K Lambaren","year":"2025","unstructured":"Lambaren, K., Trac, N., Fehrenbach, D., Madhur, M. & Chung, E. J. T cell-targeting nanotherapies for atherosclerosis. Bioconjug Chem. 36, 332\u2013346 (2025).","journal-title":"Bioconjug Chem."},{"key":"1295_CR208","doi-asserted-by":"publisher","first-page":"681062","DOI":"10.3389\/fimmu.2021.681062","volume":"12","author":"DA Horwitz","year":"2021","unstructured":"Horwitz, D. A., Bickerton, S. & La Cava, A. Strategies to use nanoparticles to generate CD4 and CD8 regulatory T cells for the treatment of SLE and other autoimmune diseases. Front. Immunol. 12, 681062 (2021).","journal-title":"Front. Immunol."},{"key":"1295_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121339","volume":"281","author":"A Kheirolomoom","year":"2022","unstructured":"Kheirolomoom, A. et al. In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift. Biomaterials 281, 121339 (2022).","journal-title":"Biomaterials"},{"key":"1295_CR210","doi-asserted-by":"publisher","first-page":"107148","DOI":"10.1016\/j.carpath.2019.107148","volume":"43","author":"JL Newman","year":"2019","unstructured":"Newman, J. L. & Stone, J. R. Immune checkpoint inhibition alters the inflammatory cell composition of human coronary artery atherosclerosis. Cardiovasc. Pathol. 43, 107148 (2019).","journal-title":"Cardiovasc. Pathol."},{"key":"1295_CR211","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2174\/1871530323666230416153426","volume":"23","author":"C Caiati","year":"2023","unstructured":"Caiati, C. & Jirillo, E. Immune checkpoint inhibitor-mediated cardiovascular disease: the dark side of the monoclonal anti-body therapy against cancer. Endocr. Metab. Immune Disord. Drug Targets 23, 1365\u20131367 (2023).","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"1295_CR212","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/cells9091987","volume":"9","author":"K Poels","year":"2020","unstructured":"Poels, K. et al. Antibody-mediated inhibition of CTLA4 aggravates atherosclerotic plaque inflammation and progression in hyperlipidemic mice. Cells 9, 1987 (2020).","journal-title":"Cells"},{"key":"1295_CR213","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","volume":"142","author":"ZD Drobni","year":"2020","unstructured":"Drobni, Z. D. et al. Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque. Circulation 142, 2299\u20132311 (2020).","journal-title":"Circulation"},{"key":"1295_CR214","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1002\/eji.200324270","volume":"33","author":"N Rodig","year":"2003","unstructured":"Rodig, N. et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 33, 3117\u20133126 (2003).","journal-title":"Eur. J. Immunol."},{"key":"1295_CR215","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1161\/CIRCULATIONAHA.107.709360","volume":"116","author":"N Grabie","year":"2007","unstructured":"Grabie, N. et al. Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell-mediated injury in the heart. Circulation 116, 2062\u20132071 (2007).","journal-title":"Circulation"},{"key":"1295_CR216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2021.11.060","volume":"349","author":"K Fujisue","year":"2022","unstructured":"Fujisue, K. et al. Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome. Int. J. Cardiol. 349, 1\u20136 (2022).","journal-title":"Int. J. Cardiol."},{"key":"1295_CR217","doi-asserted-by":"publisher","first-page":"355","DOI":"10.5551\/jat.64183","volume":"31","author":"S Miyazaki","year":"2024","unstructured":"Miyazaki, S. et al. Prognostic significance of soluble PD-L1 on cardiovascular outcomes in patients with coronary artery disease. J. Atheroscler. Thromb. 31, 355\u2013367 (2024).","journal-title":"J. Atheroscler. Thromb."},{"key":"1295_CR218","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","volume":"55","author":"C-H Koh","year":"2023","unstructured":"Koh, C.-H., Lee, S., Kwak, M., Kim, B.-S. & Chung, Y. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp. Mol. Med. 55, 2287\u20132299 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1295_CR219","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.immuni.2017.09.008","volume":"47","author":"I Tabas","year":"2017","unstructured":"Tabas, I. & Lichtman, A. H. Monocyte-macrophages and T cells in atherosclerosis. Immunity 47, 621\u2013634 (2017).","journal-title":"Immunity"},{"key":"1295_CR220","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity 54, 1561\u20131577.e1567 (2021).","journal-title":"Immunity"},{"key":"1295_CR221","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202202011","volume":"221","author":"F Bonacina","year":"2022","unstructured":"Bonacina, F. et al. The low-density lipoprotein receptor\u2013mTORC1 axis coordinates CD8+ T cell activation. J. Cell Biol. 221, e202202011 (2022).","journal-title":"J. Cell Biol."},{"key":"1295_CR222","doi-asserted-by":"publisher","DOI":"10.4110\/in.2023.23.e41","volume":"23","author":"P Topchyan","year":"2023","unstructured":"Topchyan, P., Lin, S. & Cui, W. The role of CD4 T cell help in CD8 T cell differentiation and function during chronic infection and cancer. Immune Netw. 23, e41 (2023).","journal-title":"Immune Netw."},{"key":"1295_CR223","doi-asserted-by":"publisher","first-page":"1302031","DOI":"10.3389\/fimmu.2024.1302031","volume":"15","author":"P Roy","year":"2024","unstructured":"Roy, P., Suthahar, S. S. A., Makings, J. & Ley, K. Identification of apolipoprotein B-reactive CDR3 motifs allows tracking of atherosclerosis-related memory CD4+ T cells in multiple donors. Front. Immunol. 15, 1302031 (2024).","journal-title":"Front. Immunol."},{"key":"1295_CR224","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/cells10020446","volume":"10","author":"T Marchini","year":"2021","unstructured":"Marchini, T., Hansen, S. & Wolf, D. ApoB-specific CD4+ T cells in mouse and human atherosclerosis. Cells 10, 446 (2021).","journal-title":"Cells"},{"key":"1295_CR225","doi-asserted-by":"publisher","unstructured":"Isabel Vanegas, M., Akbarian, A., Clark, K. L., Nesse, W. H. & Noudoost, B. Prefrontal activity sharpens spatial sensitivity of extrastriate neurons. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.10.25.564095 (2023).","DOI":"10.1101\/2023.10.25.564095"},{"key":"1295_CR226","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejphar.2017.05.010","volume":"816","author":"B Emini Veseli","year":"2017","unstructured":"Emini Veseli, B. et al. Animal models of atherosclerosis. Eur. J. Pharmacol. 816, 3\u201313 (2017).","journal-title":"Eur. J. Pharmacol."},{"key":"1295_CR227","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MOL.0b013e32833ded6a","volume":"21","author":"JF Bentzon","year":"2010","unstructured":"Bentzon, J. F. & Falk, E. Atherosclerotic lesions in mouse and man: is it the same disease? Curr. Opin. Lipidol. 21, 434\u2013440 (2010).","journal-title":"Curr. Opin. Lipidol."},{"key":"1295_CR228","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211446","volume":"14","author":"EW Cross","year":"2019","unstructured":"Cross, E. W., Blain, T. J., Mathew, D. & Kedl, R. M. Anti-CD8 monoclonal antibody-mediated depletion alters the phenotype and behavior of surviving CD8+ T cells. PLoS ONE 14, e0211446 (2019).","journal-title":"PLoS ONE"},{"key":"1295_CR229","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.4049\/jimmunol.1800339","volume":"201","author":"SR Jung","year":"2018","unstructured":"Jung, S. R., Suprunenko, T., Ashhurst, T. M., King, N. J. C. & Hofer, M. J. Collateral damage: what effect does anti-CD4 and anti-CD8\u03b1 antibody-mediated depletion have on leukocyte populations? J. Immunol. 201, 2176\u20132186 (2018).","journal-title":"J. Immunol."},{"key":"1295_CR230","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.179.2.661","volume":"179","author":"R Glas","year":"1994","unstructured":"Glas, R., Ohlen, C., Hoglund, P. & Karre, K. The CD8+ T cell repertoire in \u03b22-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I. J. Exp. Med. 179, 661\u2013672 (1994).","journal-title":"J. Exp. Med."},{"key":"1295_CR231","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1126\/science.adh4124","volume":"382","author":"ME Badr","year":"2023","unstructured":"Badr, M. E., Zhang, Z., Tai, X. & Singer, A. CD8 T cell tolerance results from eviction of immature autoreactive cells from the thymus. Science 382, 534\u2013541 (2023).","journal-title":"Science"},{"key":"1295_CR232","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.immuni.2015.05.001","volume":"42","author":"W Yu","year":"2015","unstructured":"Yu, W. et al. Clonal deletion prunes but does not eliminate self-specific \u03b1\u03b2CD8+ T lymphocytes. Immunity 42, 929\u2013941 (2015).","journal-title":"Immunity"},{"key":"1295_CR233","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.4049\/jimmunol.172.10.5967","volume":"172","author":"NA Danke","year":"2004","unstructured":"Danke, N. A., Koelle, D. M., Yee, C., Beheray, S. & Kwok, W. W. Autoreactive T cells in healthy individuals. J. Immunol. 172, 5967\u20135972 (2004).","journal-title":"J. Immunol."},{"key":"1295_CR234","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41577-024-01010-y","volume":"24","author":"A Khan","year":"2024","unstructured":"Khan, A., Roy, P. & Ley, K. Breaking tolerance: the autoimmune aspect of atherosclerosis. Nat. Rev. Immunol. 24, 670\u2013679 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1295_CR235","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1158\/0008-5472.CAN-06-2379","volume":"66","author":"GE Lyons","year":"2006","unstructured":"Lyons, G. E. et al. Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells. Cancer Res. 66, 11455\u201311461 (2006).","journal-title":"Cancer Res."},{"key":"1295_CR236","doi-asserted-by":"publisher","first-page":"1412513","DOI":"10.3389\/fimmu.2024.1412513","volume":"15","author":"S Srinivasan","year":"2024","unstructured":"Srinivasan, S., Zhu, C. & McShan, A. C. Structure, function, and immunomodulation of the CD8 co-receptor. Front. Immunol. 15, 1412513 (2024).","journal-title":"Front. Immunol."},{"key":"1295_CR237","doi-asserted-by":"publisher","first-page":"a037929","DOI":"10.1101\/cshperspect.a037929","volume":"13","author":"Y Muroyama","year":"2021","unstructured":"Muroyama, Y. & Wherry, E. J. Memory T-cell heterogeneity and terminology. Cold Spring Harb. Perspect. Biol. 13, a037929 (2021).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1295_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00918-7","volume":"13","author":"M Miron","year":"2021","unstructured":"Miron, M. et al. Maintenance of the human memory T cell repertoire by subset and tissue site. Genome Med. 13, 100 (2021).","journal-title":"Genome Med."},{"key":"1295_CR239","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.immuni.2018.02.010","volume":"48","author":"SC Jameson","year":"2018","unstructured":"Jameson, S. C. & Masopust, D. Understanding subset diversity in T cell memory. Immunity 48, 214\u2013226 (2018).","journal-title":"Immunity"},{"key":"1295_CR240","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DAA Vignali","year":"2008","unstructured":"Vignali, D. A. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523\u2013532 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1295_CR241","doi-asserted-by":"publisher","first-page":"708874","DOI":"10.3389\/fimmu.2021.708874","volume":"12","author":"S Mishra","year":"2021","unstructured":"Mishra, S., Srinivasan, S., Ma, C. & Zhang, N. CD8+ regulatory T cell \u2014 a mystery to be revealed. Front. Immunol. 12, 708874 (2021).","journal-title":"Front. Immunol."},{"key":"1295_CR242","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.immuni.2024.05.014","volume":"57","author":"KE Block","year":"2024","unstructured":"Block, K. E. & Jameson, S. C. CD8+ T cell tolerance: it doesn\u2019t translate. Immunity 57, 1184\u20131186 (2024).","journal-title":"Immunity"},{"key":"1295_CR243","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.immuni.2024.04.026","volume":"57","author":"W Van Der Byl","year":"2024","unstructured":"Van Der Byl, W. et al. The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects. Immunity 57, 1324\u20131344.e1328 (2024).","journal-title":"Immunity"},{"key":"1295_CR244","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.4049\/jimmunol.161.10.5260","volume":"161","author":"PM Dubois","year":"1998","unstructured":"Dubois, P. M., Pihlgren, M., Tomkowiak, M., Van Mechelen, M. & Marvel, J. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo1. J. Immunol. 161, 5260\u20135267 (1998).","journal-title":"J. Immunol."},{"key":"1295_CR245","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65615","volume":"10","author":"EN Truckenbrod","year":"2021","unstructured":"Truckenbrod, E. N. et al. CD8+ T cell self-tolerance permits responsiveness but limits tissue damage. eLife 10, e65615 (2021).","journal-title":"eLife"},{"key":"1295_CR246","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/medicina60101574","volume":"60","author":"R Shumnalieva","year":"2024","unstructured":"Shumnalieva, R. et al. Management of coronary artery diseases in systemic vasculitides: complications and strategies. Medicina 60, 1574 (2024).","journal-title":"Medicina"},{"key":"1295_CR247","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/bph.12448","volume":"170","author":"SP Alexander","year":"2013","unstructured":"Alexander, S. P. et al. The concise guide to pharmacology 2013\/14: nuclear hormone receptors. Br. J. Pharmacol. 170, 1652\u20131675 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"1295_CR248","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.carpath.2013.01.003","volume":"22","author":"T-H Lan","year":"2013","unstructured":"Lan, T.-H., Huang, X.-Q. & Tan, H.-M. Vascular fibrosis in atherosclerosis. Cardiovasc. Pathol. 22, 401\u2013407 (2013).","journal-title":"Cardiovasc. Pathol."},{"key":"1295_CR249","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/ATVBAHA.119.312705","volume":"39","author":"JM Valdivielso","year":"2019","unstructured":"Valdivielso, J. M. et al. Atherosclerosis in chronic kidney disease: more, less, or just different? Arterioscler. Thromb. Vasc. Biol. 39, 1938\u20131966 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR250","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s40620-020-00793-2","volume":"33","author":"J Kurzhagen","year":"2020","unstructured":"Kurzhagen, J., Dellepiane, S., Cantaluppi, V. & Rabb, H. AKI: an increasingly recognized risk factor for CKD development and progression. J. Nephrol. 33, 1171\u20131187 (2020).","journal-title":"J. Nephrol."},{"key":"1295_CR251","doi-asserted-by":"publisher","first-page":"17528","DOI":"10.18632\/aging.103764","volume":"12","author":"J Wang","year":"2020","unstructured":"Wang, J., Tian, J., Sun, J., Gao, M. & Dong, Y. Two identified subsets of CD8 T cells in obstructed kidneys play different roles in inflammation and fibrosis. Aging 12, 17528 (2020).","journal-title":"Aging"},{"key":"1295_CR252","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/biom11070990","volume":"11","author":"M Gao","year":"2021","unstructured":"Gao, M., Wang, J., Zang, J., An, Y. & Dong, Y. The mechanism of CD8+ T cells for reducing myofibroblasts accumulation during renal fibrosis. Biomolecules 11, 990 (2021).","journal-title":"Biomolecules"},{"key":"1295_CR253","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131731","volume":"10","author":"T Honjo","year":"2015","unstructured":"Honjo, T. et al. Immunization with an ApoB-100 related peptide vaccine attenuates angiotensin-II induced hypertension and renal fibrosis in mice. PLoS ONE 10, e0131731 (2015).","journal-title":"PLoS ONE"},{"key":"1295_CR254","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24734-0","volume":"12","author":"Y Koda","year":"2021","unstructured":"Koda, Y. et al. CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nat. Commun. 12, 4474 (2021).","journal-title":"Nat. Commun."},{"key":"1295_CR255","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang, M. & Zhang, S. T cells in fibrosis and fibrotic diseases. Front. Immunol. 11, 1142 (2020).","journal-title":"Front. Immunol."},{"key":"1295_CR256","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1040233","volume":"13","author":"K Brassington","year":"2022","unstructured":"Brassington, K. et al. Crosstalk between cytotoxic CD8+ T cells and stressed cardiomyocytes triggers development of interstitial cardiac fibrosis in hypertensive mouse hearts. Front. Immunol. 13, 1040233 (2022).","journal-title":"Front. Immunol."},{"key":"1295_CR257","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/cells11192963","volume":"11","author":"E D\u2019Alessandro","year":"2022","unstructured":"D\u2019Alessandro, E., Winters, J., van Nieuwenhoven, F. A., Schotten, U. & Verheule, S. The complex relation between atrial cardiomyopathy and thrombogenesis. Cells 11, 2963 (2022).","journal-title":"Cells"},{"key":"1295_CR258","doi-asserted-by":"publisher","first-page":"1578148","DOI":"10.3389\/fcvm.2025.1578148","volume":"12","author":"Z Pang","year":"2025","unstructured":"Pang, Z., Ren, Y. & Yao, Z. Interactions between atrial fibrosis and inflammation in atrial fibrillation. Front. Cardiovasc. Med. 12, 1578148 (2025).","journal-title":"Front. Cardiovasc. Med."},{"key":"1295_CR259","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/cells12010141","volume":"12","author":"J Friebel","year":"2023","unstructured":"Friebel, J. et al. Cytotoxic CD8+ T cells are involved in the thrombo-inflammatory response during first-diagnosed atrial fibrillation. Cells 12, 141 (2023).","journal-title":"Cells"},{"key":"1295_CR260","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3389\/fimmu.2018.01075","volume":"9","author":"JN Rashida Gnanaprakasam","year":"2018","unstructured":"Rashida Gnanaprakasam, J. N., Wu, R. & Wang, R. Metabolic reprogramming in modulating T cell reactive oxygen species generation and antioxidant capacity. Front. Immunol. 9, 1075 (2018).","journal-title":"Front. Immunol."},{"key":"1295_CR261","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13046-022-02439-6","volume":"41","author":"L Zhang","year":"2022","unstructured":"Zhang, L. et al. Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review. J. Exp. Clin. Cancer Res. 41, 227 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1295_CR262","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.4049\/jimmunol.174.10.6080","volume":"174","author":"A Takahashi","year":"2005","unstructured":"Takahashi, A. et al. Preferential cell death of CD8+ effector memory (CCR7\u2212CD45RA\u2212) T cells by hydrogen peroxide-induced oxidative stress. J. Immunol. 174, 6080\u20136087 (2005).","journal-title":"J. Immunol."},{"key":"1295_CR263","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","volume":"84","author":"R Stocker","year":"2004","unstructured":"Stocker, R. & Keaney, J. F. Jr. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381\u20131478 (2004).","journal-title":"Physiol. Rev."},{"key":"1295_CR264","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P. & Malik, A. B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20, 1126\u20131167 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"1295_CR265","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1158\/1078-0432.CCR-16-2677","volume":"23","author":"DJ Messenheimer","year":"2017","unstructured":"Messenheimer, D. J. et al. Timing of PD-1 blockade is critical to effective combination immunotherapy with anti-OX40. Clin. Cancer Res. 23, 6165\u20136177 (2017).","journal-title":"Clin. Cancer Res."},{"key":"1295_CR266","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9819","volume":"6","author":"A Bai","year":"2015","unstructured":"Bai, A. et al. NADH oxidase-dependent CD39 expression by CD8+ T cells modulates interferon \u03b3 responses via generation of adenosine. Nat. Commun. 6, 8819 (2015).","journal-title":"Nat. Commun."},{"key":"1295_CR267","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.551758","volume":"11","author":"BL Zaric","year":"2020","unstructured":"Zaric, B. L. et al. Atherosclerosis linked to aberrant amino acid metabolism and immunosuppressive amino acid catabolizing enzymes. Front. Immunol. 11, 551758 (2020).","journal-title":"Front. Immunol."},{"key":"1295_CR268","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3390\/biom14121557","volume":"14","author":"Y Wu","year":"2024","unstructured":"Wu, Y., Avcilar-K\u00fcc\u00fckg\u00f6ze, I., Santovito, D. & Atzler, D. Amino acid metabolism and autophagy in atherosclerotic cardiovascular disease. Biomolecules 14, 1557 (2024).","journal-title":"Biomolecules"},{"key":"1295_CR269","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/ATVBAHA.118.311572","volume":"39","author":"K Nitz","year":"2019","unstructured":"Nitz, K., Lacy, M. & Atzler, D. Amino acids and their metabolism in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 39, 319\u2013330 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR270","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ajpath.2023.12.006","volume":"194","author":"SK Anand","year":"2024","unstructured":"Anand, S. K. et al. Amino acid metabolism and atherosclerotic cardiovascular disease. Am. J. Pathol. 194, 510\u2013524 (2024).","journal-title":"Am. J. Pathol."},{"key":"1295_CR271","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12986-024-00857-1","volume":"21","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Association between tryptophan concentrations and the risk of developing cardiovascular diseases: a systematic review and meta-analysis. Nutr. Metab. 21, 82 (2024).","journal-title":"Nutr. Metab."},{"key":"1295_CR272","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/CIRCULATIONAHA.105.576702","volume":"113","author":"E Stabile","year":"2006","unstructured":"Stabile, E. et al. CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation 113, 118\u2013124 (2006).","journal-title":"Circulation"},{"key":"1295_CR273","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/ATVBAHA.122.318079","volume":"43","author":"D Deliyanti","year":"2023","unstructured":"Deliyanti, D. et al. CD8+ T cells promote pathological angiogenesis in ocular neovascular disease. Arterioscler. Thromb. Vasc. Biol. 43, 522\u2013536 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR274","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","volume":"52","author":"WS Lee","year":"2020","unstructured":"Lee, W. S., Yang, H., Chon, H. J. & Kim, C. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Exp. Mol. Med. 52, 1475\u20131485 (2020).","journal-title":"Exp. Mol. Med."},{"key":"1295_CR275","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s12272-022-01389-z","volume":"45","author":"HJ Kim","year":"2022","unstructured":"Kim, H. J., Ji, Y. R. & Lee, Y. M. Crosstalk between angiogenesis and immune regulation in the tumor microenvironment. Arch. Pharm. Res. 45, 401\u2013416 (2022).","journal-title":"Arch. Pharm. Res."},{"key":"1295_CR276","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1165\/rcmb.2015-0087OC","volume":"54","author":"Q Zhong","year":"2016","unstructured":"Zhong, Q., Jenkins, J., Moldobaeva, A., D\u2019Alessio, F. & Wagner, E. M. Effector T cells and ischemia-induced systemic angiogenesis in the lung. Am. J. Respir. Cell Mol. Biol. 54, 394\u2013401 (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1295_CR277","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ni.2714","volume":"14","author":"AL Doedens","year":"2013","unstructured":"Doedens, A. L. et al. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen. Nat. Immunol. 14, 1173\u20131182 (2013).","journal-title":"Nat. Immunol."},{"key":"1295_CR278","doi-asserted-by":"publisher","first-page":"328","DOI":"10.18632\/aging.101726","volume":"11","author":"F Jin","year":"2019","unstructured":"Jin, F. et al.Impairment of hypoxia-induced angiogenesis by LDL involves a HIF-centered signaling network linking inflammatory TNF\u03b1 and angiogenic VEGF. Aging11, 328\u2013349 (2019).","journal-title":"Aging"},{"key":"1295_CR279","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MOL.0000000000000210","volume":"26","author":"VW van Hinsbergh","year":"2015","unstructured":"van Hinsbergh, V. W., Eringa, E. C. & Daemen, M. J. Neovascularization of the atherosclerotic plaque: interplay between atherosclerotic lesion, adventitia-derived microvessels and perivascular fat. Curr. Opin. Lipidol. 26, 405\u2013411 (2015).","journal-title":"Curr. Opin. Lipidol."},{"key":"1295_CR280","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1161\/ATVBAHA.123.318233","volume":"43","author":"A Shakeri","year":"2023","unstructured":"Shakeri, A. et al. Engineering organ-on-a-chip systems for vascular diseases. Arterioscler. Thromb. Vasc. Biol. 43, 2241\u20132255 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR281","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1161\/ATVBAHA.124.321332","volume":"44","author":"R Maringanti","year":"2024","unstructured":"Maringanti, R. et al. Atherosclerosis on a chip: a 3-dimensional microfluidic model of early arterial events in human plaques. Arterioscler. Thromb. Vasc. Biol. 44, 2453\u20132472 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1295_CR282","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.actbio.2024.07.036","volume":"186","author":"I Tandon","year":"2024","unstructured":"Tandon, I. et al. A three-dimensional valve-on-chip microphysiological system implicates cell cycle progression, cholesterol metabolism and protein homeostasis in early calcific aortic valve disease progression. Acta Biomater. 186, 167\u2013184 (2024).","journal-title":"Acta Biomater."},{"key":"1295_CR283","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280385","volume":"18","author":"M Liu","year":"2023","unstructured":"Liu, M. et al. Co-culture models of endothelial cells, macrophages, and vascular smooth muscle cells for the study of the natural history of atherosclerosis. PLoS ONE 18, e0280385 (2023).","journal-title":"PLoS ONE"},{"key":"1295_CR284","doi-asserted-by":"publisher","first-page":"8234","DOI":"10.3390\/ijms22158234","volume":"22","author":"L de Haan","year":"2021","unstructured":"de Haan, L. et al. A microfluidic 3D endothelium-on-a-chip model to study transendothelial migration of T cells in health and disease. Int. J. Mol. Sci. 22, 8234 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1295_CR285","first-page":"88","volume":"40","author":"X Du","year":"2024","unstructured":"Du, X., Jia, H., Chang, Y., Zhao, Y. & Song, J. Progress of organoid platform in cardiovascular research. Bioact. Mater. 40, 88\u2013103 (2024).","journal-title":"Bioact. Mater."},{"key":"1295_CR286","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/cei\/uxae004","volume":"218","author":"D Papp","year":"2024","unstructured":"Papp, D., Korcsmaros, T. & Hautefort, I. Revolutionizing immune research with organoid-based co-culture and chip systems. Clin. Exp. Immunol. 218, 40\u201354 (2024).","journal-title":"Clin. Exp. Immunol."},{"key":"1295_CR287","first-page":"164","volume":"44","author":"IR Suhito","year":"2025","unstructured":"Suhito, I. R., Sunil, C. & Tay, A. Engineering human immune organoids for translational immunology. Bioact. Mater. 44, 164\u2013183 (2025).","journal-title":"Bioact. Mater."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01295-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01295-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01295-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T10:04:17Z","timestamp":1778061857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01295-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":287,"alternative-id":["1295"],"URL":"https:\/\/doi.org\/10.1038\/s41569-026-01295-7","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"13 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}